Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:MSA
NYSE:MSACommercial Services

MSA Safety (MSA) And The Valuation Case Behind Its Connected Safety Story

MSA Safety (MSA) is in focus after fresh analysis highlighted a 14.1% compound annual EPS growth over five years and a 6.6 percentage point expansion in free cash flow margin, alongside slower recent revenue growth. See our latest analysis for MSA Safety. At a share price of $171.48, MSA Safety has delivered a 5.0% 30 day share price return and a 5.7% year to date share price return, while the 1 year total shareholder return has slipped 1.3%. This suggests that shorter term momentum contrasts...
NYSE:TGT
NYSE:TGTConsumer Retailing

Does Target’s (TGT) Index Move and Sales Upgrade Reframe Its Defensive Retail Narrative?

In late June 2026, Target Corporation (NYSE:TGT) was added to the Russell 1000 Value-Defensive and Russell 1000 Defensive Indexes after reporting a broad-based, traffic-led sales rebound and raising its fiscal 2026 net sales growth outlook to around 4%, up from roughly 2%. The company is pairing this improved sales outlook with refreshed seasonal assortments and brand partnerships, such as its renewed Parachute collaboration, to strengthen its merchandise mix across both in-store and digital...
NYSE:AGM
NYSE:AGMDiversified Financial

How Investors Are Reacting To Federal Agricultural Mortgage (AGM) Resilient Rural Lending Strengthening Its Investment Narrative

In recent coverage of Federal Agricultural Mortgage, analysts highlighted how its diversified segments across Farm & Ranch, Corporate AgFinance, and Infrastructure Finance helped it handle industry headwinds from elevated mortgage rates while delivering double-digit year-over-year gains in business volume, revenues, and core earnings earlier in 2026. An interesting angle is how this multi-segment footprint in rural America, combined with disciplined underwriting and steady customer demand,...
SEHK:2007
SEHK:2007Real Estate

Country Garden Holdings (SEHK:2007) Reports Weaker Sales, Is The Valuation Gap Justified?

Country Garden Holdings (SEHK:2007) has reported June contracted sales of about CN¥2.45b, down 13% year-on-year. The company also reported weaker first half sales and its first interest payment under a major offshore debt restructuring. See our latest analysis for Country Garden Holdings. The June sales update and progress on offshore debt restructuring come after a mixed price pattern for Country Garden Holdings, with the share price up 8.67% over one day and 10.59% over seven days, but down...
NYSE:FNB
NYSE:FNBBanks

F.N.B (FNB) Could Be 38% Undervalued On Earnings Driven Momentum

Why F.N.B Stock Is Back On Investors’ Radar F.N.B (FNB) has drawn fresh attention after its latest quarterly earnings report, where revenue came in slightly below forecasts but earnings per share matched expectations and earnings grew 19% year over year. See our latest analysis for F.N.B. Since the results, F.N.B's share price has gained 9.5% over the past month and 12.9% over the past quarter, while the 1 year total shareholder return of 25.7% and 5 year total shareholder return of 95.5%...
NYSE:MBGL
NYSE:MBGLProfessional Services

Is Mobility Global (MBGL) Cheap Following Its Spin Off From S&P Global?

Mobility Global (MBGL) has just completed its spin off from S&P Global, with shares distributed to existing S&P Global investors and trading beginning on the New York Stock Exchange on July 1, 2026. See our latest analysis for Mobility Global. After the spin off, Mobility Global’s 1 day share price return declined 6.56% and its year to date share price return is down 5.69%. This suggests early trading pressure even as the stock joins multiple global indices and completes a broad board...
NYSE:IBP
NYSE:IBPConsumer Durables

How New 21st Century ROAD to Housing Act At Installed Building Products (IBP) Has Changed Its Investment Story

Earlier this week, Congress passed the bipartisan 21st Century ROAD to Housing Act, a housing-focused law that investors expect to support construction-related businesses such as Installed Building Products. The legislation’s emphasis on addressing housing demand has drawn attention to companies leveraged to commercial and multifamily construction, spotlighting Installed Building Products’ positioning across these segments. Next, we’ll examine how the new housing law’s focus on demand and...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Is FuboTV (FUBO) Undervalued As Patent Lawsuit Risk Meets A 0.1x P S Ratio?

Adeia Inc. has filed a patent infringement lawsuit against FuboTV (FUBO) in the U.S. District Court for the District of Delaware, alleging unauthorized use of four media streaming technology patents. See our latest analysis for FuboTV. FuboTV's share price has been volatile, with a 26.08% 7 day share price return and a 4.40% 90 day share price return, yet the year to date share price return and 1 year total shareholder return are both sharply negative. This suggests that recent momentum...
SEHK:2727
SEHK:2727Electrical

Shanghai Electric Group (SEHK:2727) Wins Arbitration As Fair Value Questions Remain

Shanghai Electric Group (SEHK:2727) is back in focus after the Singapore International Arbitration Centre dismissed all substantive claims brought by Oxagon Enterprises with prejudice, reducing legal overhang while leaving profit implications dependent on future enforcement. See our latest analysis for Shanghai Electric Group. Despite the legal win, Shanghai Electric Group’s recent 7 day share price return of 3.89% only partly offsets a 30 day share price decline of 15.98%. However, the 1...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Harrow (HROW) Could Be 38% Undervalued Following BYOOVIZ Launch

Why Harrow stock is in focus after the BYOOVIZ launch Harrow (HROW) is back on investors’ radar after launching BYOOVIZ in the US, a Lucentis biosimilar that carries FDA interchangeability status for several retinal conditions tied to anti VEGF treatment. See our latest analysis for Harrow. Harrow’s official BYOOVIZ launch comes after a sharp 28.27% 1 month share price gain and a 21.04% 3 month share price return, while the year to date share price is still down 14.37%. Over the longer term,...
NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

Pool (POOL) Faces A Valuation Test Following Russell Growth Index Removals

Index removals put Pool stock in focus Pool (POOL) has been dropped from several Russell growth indices, including the Russell 1000 Growth and Russell 3000 Growth, a change that can influence trading as index tracking funds rebalance holdings. For you as an investor, this kind of index removal often affects short term supply and demand for the stock, separate from how the underlying pool supplies distribution business is performing or what its fundamentals look like. See our latest analysis...
SGX:BSL
SGX:BSLHealthcare

Raffles Medical Group (SGX:BSL) AI Imaging Deal Puts Its Valuation Back In Focus

Raffles Medical Group (SGX:BSL) has drawn attention after signing a supply agreement with Neurophet for Neurophet AQUA, AI driven brain MRI analysis software used in assessing neurodegenerative conditions such as Alzheimer’s disease and vascular dementia. See our latest analysis for Raffles Medical Group. At a share price of SGD0.93, Raffles Medical Group has seen a 1 day share price return of 1.09%, while its year to date share price return is down 8.82% and the 1 year total shareholder...
CASE:EFID
CASE:EFIDFood

China Tariff Cut Puts Edita Stock And African Exporters In Focus

China’s decision to scrap tariffs on products from 53 African countries has put a fresh spotlight on African export oriented manufacturing stocks, especially those already selling into, or capable of supplying, the Chinese market. With trade terms improving overnight and potential for export volumes to rise 15 to 25% over the next few years, investors are asking which companies might stand to gain most, and which could struggle if they fail to keep up. This article looks at 3 stocks from our...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Datadog Stock And 2 Enterprise Software Picks Tied to Fed Policy

With the Federal Reserve signaling a slower path on cutting its $6.7 trillion balance sheet and keeping interest rates as its primary tool, large-cap growth stocks are facing a very different backdrop than many investors expected. Instead of bracing for aggressive tightening, you are looking at a world where policy shifts are more gradual and heavily telegraphed, which can matter a lot for how growth companies are priced. This article walks through 3 large-cap growth stocks from our screener...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Did FDA’s Facility-Related LNTH-2501 Delay and Russell Additions Just Reframe Lantheus Holdings’ (LNTH) Risk Profile?

In late June 2026, Lantheus Holdings reported that the FDA issued a Complete Response Letter for its LNTH-2501 PET imaging kit for somatostatin receptor‑positive neuroendocrine tumors, citing unresolved third‑party manufacturing facility issues rather than concerns about the product’s safety, efficacy, or supporting data. Separately, the company was added to both the Russell 2000 Defensive Index and the Russell 2000 Growth‑Defensive Index, highlighting its growing profile within defensive...
ASX:PXA
ASX:PXAReal Estate

Does PEXA Group’s (ASX:PXA) UK Co-CEO Move Reframe Its Regulatory And Expansion Risk Narrative?

PEXA Group recently announced a leadership reshuffle in its UK business, appointing Krystle Kocik and Simon Wright as Co-CEOs, alongside adding two independent non-executive directors, Janelle Hopkins and John Hooper, to its board. These leadership and governance changes, combined with PEXA’s engagement on IPART’s draft review of ELNO service fees, could reshape how investors assess its UK expansion and regulatory risk profile. We’ll now examine how the new Co-CEO structure in PEXA UK may...
TSX:ONEX
TSX:ONEXCapital Markets

Onex (TSX:ONEX) Faces A Valuation Test After Its Planned CEO Handover

Onex (TSX:ONEX) is entering a leadership transition, with founder Gerry Schwartz set to step down as CEO after the next annual meeting while remaining chairman, and long-time executive Bobby Le Blanc becoming CEO. See our latest analysis for Onex. The leadership news comes as Onex shares trade at CA$108.97, with a 1-day share price return of 2.74% and a 7-day share price return of 4.03%, while the year-to-date share price return is down 4.40% and the 3-year total shareholder return is 50.71%...
NYSE:MA
NYSE:MADiversified Financial

What Mastercard (MA) Joining Open USD Means For Its Valuation

Mastercard (MA) has joined more than 140 partners to back Open USD, a US dollar pegged stablecoin designed to enable low cost, high throughput and accessible digital payments for cross border and commercial use. See our latest analysis for Mastercard. Recent news around Open USD, VEON partnerships and the Africa Cybersecurity Center of Excellence has coincided with a sharp short term rebound in Mastercard. The 7 day share price return is 10.32% and the 1 month share price return is 12.92%,...
NasdaqGS:OSBC
NasdaqGS:OSBCBanks

Old Second Bancorp (OSBC) Joined Russell Indexes And Unveiled A Buyback, Is The Upside Priced In?

Why Old Second Bancorp’s latest index moves and buyback matter Old Second Bancorp (OSBC) has drawn fresh attention after being added to multiple Russell growth and small cap benchmark indexes and unveiling a share repurchase program of up to US$61.2 million. See our latest analysis for Old Second Bancorp. Old Second Bancorp’s recent inclusion in several Russell growth and small cap indexes and the new buyback plan come as the stock trades at US$23.23, with a 30 day share price return of 8.75%...
NasdaqGS:PEP
NasdaqGS:PEPBeverage

Is PepsiCo (PEP) Undervalued As Elliott, A $10b Buyback, And Q2 Near?

PepsiCo (PEP) has moved back into focus after Elliott Investment Management disclosed a large activist stake, coinciding with a new US$10b buyback authorization, a fresh dividend increase, and rising attention on upcoming Q2 earnings. See our latest analysis for PepsiCo. PepsiCo’s recent news flow around Elliott’s activist stake, the new US$10b buyback, and brand campaigns such as Mountain Dew’s TikTok Shop drop and Doritos Loaded’s Formula 1 tie in comes after a mixed run. The 1-day share...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

How Marex’s Shift to Bermuda and Russell 2000 Exit At Marex Group (MRX) Has Changed Its Investment Story

Marex Group plc recently completed its redomiciliation from England and Wales to Bermuda, following shareholder approval, global regulatory clearances, and sanction by the English High Court, with the move becoming effective on 1 July 2026. This shift places Marex under Bermuda’s US-style corporate law, aligning more closely with its Nasdaq listing and aiming to simplify its structure and reduce operating costs. We’ll now examine how Marex’s move to Bermuda, alongside its removal from...
NasdaqGS:STNE
NasdaqGS:STNEDiversified Financial

Does StoneCo’s Russell Index Additions and Upbeat Forecasts Change The Bull Case For STNE?

In late June 2026, StoneCo Ltd. (NasdaqGS: STNE) was added to multiple Russell value indexes, including the Russell 2000, 2500, 3000, 3000E and Small Cap Comp Value benchmarks. This wave of index inclusions coincides with upbeat analyst expectations ahead of StoneCo’s upcoming earnings release, including a favorable Zacks Rank of #2 (Buy) and projected earnings and revenue growth. We’ll now examine how this combination of index additions and upbeat analyst sentiment may influence StoneCo’s...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

Is Zoom (ZM) Quietly Recasting Its Core Identity Around Regulated, AI-Driven Customer Experience Workflows?

In recent weeks, Alvaria and Canary Speech each launched integrations with Zoom’s Contact Center and telehealth workflows, while Zoom introduced new AI tools for its Virtual Agent that speed deployment, monitoring, and optimization of customer-facing AI agents. Together, these moves deepen Zoom’s role in regulated and healthcare use cases by combining compliance controls, behavioral health insights, and AI-first customer experience automation on a single platform. Next, we’ll examine how...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Amneal Pharmaceuticals (AMRX) Gets EU Backing For Hopledo, Is It Fully Priced?

Amneal Pharmaceuticals (AMRX) is back in focus after regulators in Europe issued a positive opinion on Hopledo, a modified release levodopa/carbidopa therapy for Parkinson’s disease, spotlighting the company’s growing central nervous system franchise. See our latest analysis for Amneal Pharmaceuticals. The recent CHMP opinion and Amneal Pharmaceuticals’ addition to multiple Russell 2000 defensive indexes come after a period of strong momentum, with a 30 day share price return of 35.57% and a...